-
10857-5A synthetic analog of natural AHLs that suppresses host immunity without inducing LasR inhibits the proliferation of mouse peripheral blood leukocytes by concanavalin A (EC50 = 9.3 &muM) without concurrent cytotoxicity does not induce LasR at 100
-
11140-1A thiophene carboximide derivative proposed to inhibit IKK2 likely to be useful in the treatment of inflammatory diseases and cancer.
-
11140-10A thiophene carboximide derivative proposed to inhibit IKK2 likely to be useful in the treatment of inflammatory diseases and cancer.
-
11140-5A thiophene carboximide derivative proposed to inhibit IKK2 likely to be useful in the treatment of inflammatory diseases and cancer.
-
11042-100A 1,3 disubstituted urea derivative of 17(R),18(S)-EpETE that is more metabolically robust and reduces the contractility of cardiomyocytes with improved potency (EC50 fold higher than required for the effect on cardiomyocytes, 1-5 &muM CAY10662
-
11042-25A 1,3 disubstituted urea derivative of 17(R),18(S)-EpETE that is more metabolically robust and reduces the contractility of cardiomyocytes with improved potency (EC50 fold higher than required for the effect on cardiomyocytes, 1-5 &muM CAY10662
-
11042-50A 1,3 disubstituted urea derivative of 17(R),18(S)-EpETE that is more metabolically robust and reduces the contractility of cardiomyocytes with improved potency (EC50 fold higher than required for the effect on cardiomyocytes, 1-5 &muM CAY10662
-
11042-500A 1,3 disubstituted urea derivative of 17(R),18(S)-EpETE that is more metabolically robust and reduces the contractility of cardiomyocytes with improved potency (EC50 fold higher than required for the effect on cardiomyocytes, 1-5 &muM CAY10662
-
11044-100A bioisostere of 17,18-EET which is approximately 50% more effective at reducing arrhythmic contraction frequency, without affecting amplitude, when tested at 30 nM.
-
11044-25A bioisostere of 17,18-EET which is approximately 50% more effective at reducing arrhythmic contraction frequency, without affecting amplitude, when tested at 30 nM.
-
11044-50A bioisostere of 17,18-EET which is approximately 50% more effective at reducing arrhythmic contraction frequency, without affecting amplitude, when tested at 30 nM.
-
11044-500A bioisostere of 17,18-EET which is approximately 50% more effective at reducing arrhythmic contraction frequency, without affecting amplitude, when tested at 30 nM.